Uploads Contact
/
Login Upload

  • Search Results for 'A Phase 3 Trial Comparing Talazoparib An Oral Parp Inhibitor To Physician S Choice Of Therapy'

PARP Inhibitors and Cancer: What Do You Need to Know?
PARP Inhibitors and Cancer: What Do You Need to Know?
pasty-toler
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
conchita-marotz
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
marina-yarberry
The Use of PARP Inhibitors in Breast Cancer: Challenges
The Use of PARP Inhibitors in Breast Cancer: Challenges
calandra-battersby
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
ellena-manuel
David R.
David R.
alida-meadow
Biomarkers in Phase II designs in cancer clinical trials
Biomarkers in Phase II designs in cancer clinical trials
conchita-marotz
Carbohydrate absorption inhibitors α - glucosidose inhibitors
Carbohydrate absorption inhibitors α - glucosidose inhibitors
faustina-dinatale
Antithrombotic Therapy Taylor B Goot MD
Antithrombotic Therapy Taylor B Goot MD
cheryl-pisano
Case Discussion: Second
Case Discussion: Second
celsa-spraggs
PCR Application:
PCR Application:
alexa-scheidler
Factor VIII Inhibitors Inhibitor Development
Factor VIII Inhibitors Inhibitor Development
aaron
Her-2 negative MBC
Her-2 negative MBC
conchita-marotz
Phase I and Phase II trial design in
Phase I and Phase II trial design in
tatiana-dople
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
ellena-manuel
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
giovanna-bartolotta
1 New Treatment Opportunity: Valganciclovir
1 New Treatment Opportunity: Valganciclovir
tatyana-admore
Phase I Trial Designs Jud Blatchford, PhD
Phase I Trial Designs Jud Blatchford, PhD
faustina-dinatale
Best Practices in Nursing Management of EGFR Inhibitor Rash
Best Practices in Nursing Management of EGFR Inhibitor Rash
olivia-moreira
Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy
Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy
aaron
Dual Antiretroviral Therapy
Dual Antiretroviral Therapy
debby-jeon
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
pamella-moone
A phase III trial of adjuvant capecitabine in breast cancer
A phase III trial of adjuvant capecitabine in breast cancer
myesha-ticknor
phase ii STUDY designs:
phase ii STUDY designs:
calandra-battersby